T. Rowe Price Associates’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$686M Sell
2,572,843
-3,697,370
-59% -$1.02B 0.08% 201
2025
Q4
$1.73B Sell
6,270,213
-5,032,153
-45% -$1.41B 0.19% 100
2025
Q3
$3.26B Buy
11,302,366
+1,008,534
+10% +$298M 0.35% 45
2025
Q2
$3.4B Sell
10,293,832
-1,762,974
-15% -$568M 0.39% 41
2025
Q1
$3.97B Buy
12,056,806
+1,094,327
+10% +$330M 0.49% 36
2024
Q4
$3.03B Sell
10,962,479
-1,117,751
-9% -$356M 0.35% 44
2024
Q3
$4.19B Sell
12,080,230
-316,628
-3% -$109M 0.48% 37
2024
Q2
$4.1B Sell
12,396,858
-1,944,375
-14% -$670M 0.49% 34
2024
Q1
$5.21B Buy
14,341,233
+867,180
+6% +$285M 0.64% 22
2023
Q4
$4.03B Sell
13,474,053
-238,784
-2% -$69.8M 0.54% 27
2023
Q3
$3.92B Sell
13,712,837
-144,807
-1% -$41.3M 0.57% 26
2023
Q2
$3.89B Buy
13,857,644
+995,817
+8% +$259M 0.54% 29
2023
Q1
$3.29B Sell
12,861,827
-794,781
-6% -$232M 0.49% 44
2022
Q4
$4.52B Sell
13,656,608
-845,837
-6% -$268M 0.73% 24
2022
Q3
$4.02B Sell
14,502,445
-1,215,679
-8% -$342M 0.66% 29
2022
Q2
$4.14B Sell
15,718,124
-1,849,668
-11% -$477M 0.52% 32
2022
Q1
$4.21B Sell
17,567,792
-393,540
-2% -$92.1M 0.42% 38
2021
Q4
$4.12B Buy
17,961,332
+597,424
+3% +$127M 0.37% 46
2021
Q3
$3.48B Sell
17,363,908
-6,744,981
-28% -$1.47B 0.33% 60
2021
Q2
$5.72B Sell
24,108,889
-4,058,870
-14% -$1.01B 0.53% 32
2021
Q1
$6.81B Sell
28,167,759
-1,711,626
-6% -$382M 0.68% 21
2020
Q4
$6.21B Buy
29,879,385
+122,245
+0.4% +$24M 0.64% 25
2020
Q3
$5.04B Sell
29,757,140
-1,415,835
-5% -$249M 0.58% 26
2020
Q2
$5.85B Buy
31,172,975
+1,767,040
+6% +$335M 0.74% 20
2020
Q1
$5.21B Buy
29,405,935
+4,758,978
+19% +$923M 0.82% 17
2019
Q4
$5.04B Buy
24,646,957
+799,899
+3% +$147M 0.65% 29
2019
Q3
$3.62B Sell
23,847,058
-4,091,650
-15% -$666M 0.51% 38
2019
Q2
$4.4B Sell
27,938,708
-2,417,017
-8% -$379M 0.62% 28
2019
Q1
$4.88B Buy
30,355,725
+2,922,288
+11% +$534M 0.72% 20
2018
Q4
$5.21B Buy
27,433,437
+4,214,711
+18% +$879M 0.88% 13
2018
Q3
$4.84B Buy
23,218,726
+5,590,272
+32% +$1.04B 0.71% 18
2018
Q2
$3B Buy
17,628,454
+603,484
+4% +$104M 0.46% 42
2018
Q1
$2.86B Sell
17,024,970
-731,599
-4% -$142M 0.45% 43
2017
Q4
$3.61B Buy
17,756,569
+668,042
+4% +$133M 0.59% 28
2017
Q3
$3.19B Buy
17,088,527
+1,151,213
+7% +$205M 0.55% 32
2017
Q2
$2.67B Buy
15,937,314
+1,654,367
+12% +$266M 0.48% 38
2017
Q1
$2.09B Buy
14,282,947
+661,269
+5% +$97.4M 0.39% 56
2016
Q4
$1.82B Sell
13,621,678
-274,825
-2% -$36M 0.36% 69
2016
Q3
$1.81B Buy
13,896,503
+2,180,508
+19% +$285M 0.36% 65
2016
Q2
$1.5B Sell
11,715,995
-2,332,142
-17% -$308M 0.32% 67
2016
Q1
$1.93B Buy
14,048,137
+1,264,724
+10% +$174M 0.41% 48
2015
Q4
$1.87B Sell
12,783,413
-2,471,781
-16% -$340M 0.39% 57
2015
Q3
$2.06B Sell
15,255,194
-4,289,766
-22% -$623M 0.46% 46
2015
Q2
$3.17B Buy
19,544,960
+10,392,168
+114% +$1.44B 0.65% 25
2015
Q1
$1.18B Buy
9,152,792
+158,913
+2% +$18.5M 0.24% 102
2014
Q4
$926M Buy
8,993,879
+3,421,735
+61% +$337M 0.2% 129
2014
Q3
$505M Buy
5,572,144
+1,491,135
+37% +$139M 0.11% 219
2014
Q2
$375M Buy
4,081,009
+318,810
+8% +$27.3M 0.08% 289
2014
Q1
$315M Sell
3,762,199
-757,861
-17% -$62.4M 0.07% 321
2013
Q4
$395M Buy
4,520,060
+103,950
+2% +$8.5M 0.09% 267
2013
Q3
$339M Buy
4,416,110
+183,680
+4% +$14.3M 0.08% 278
2013
Q2
$307M Buy
+4,232,430
New +$285M 0.08% 294

Other funds holding CI

T. Rowe Price Associates's CI Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Cigna (CI) stake by 59% in Q1 2026, selling an estimated $1.02B and leaving 2,572,843 shares worth $686M. The position accounts for 0.08% of the portfolio, ranked #201.

T. Rowe Price Associates first reported a position in CI in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.81B in Q1 2021. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • T. Rowe Price Associates held 2,572,843 shares of Cigna worth $686M as of Q1 2026.
  • T. Rowe Price Associates sold 3,697,370 Cigna shares in Q1 2026, an estimated $1.02B.
  • Cigna made up 0.08% of T. Rowe Price Associates's portfolio in Q1 2026, its #201 holding.
  • T. Rowe Price Associates first reported a position in Cigna in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Cigna position peaked at $6.81B in Q1 2021.
  • 1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.